Icon Interventional Systems
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Icon Interventional Systems
Hospira’s Symbiq 3.13 infusion pump and Organogenesis’ Gintuit oral soft tissue regeneration product are new on the market.
Which kinds of innovations make for incremental enhancements in the hands of large companies and which are meaningful enough to sustain a venture-backed start-up company? In a mature market for coronary stents dominated by large companies, start-ups developing new stents need to find the answers. Areas of innovation fall into four basic categories: improving stent safety and biocompatibility, avoiding the need for dual antiplatelet therapy, enhancing deliverability, and introducing specialty stents for complex vessels. Three companies profiled here have a plan for taking sufficient market share, reducing risk, and rewarding investors.
- Medical Devices